International Multicentre, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Patients With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan
Phase of Trial: Phase IV
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Azilsartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Takeda
- 11 Sep 2017 Planned End Date changed from 1 Apr 2018 to 1 Sep 2018.
- 11 Sep 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Sep 2018.
- 23 Aug 2017 Planned End Date changed from 1 Mar 2018 to 1 Apr 2018.